Uncategorized
Where Stoke Therapeutics Stands With Analysts
Latest Ratings for STOK Date Firm Action From To Jan 2022 Jefferies Initiates Coverage On Buy Dec 2021 B of A Securities Initiates Coverage On Buy Nov 2021 JP Morgan Upgrades Neutral Overweight View More Analyst Ratings for STOK View the Latest Analyst Ratings read more
Missed Opt-Out Deadline Could Cost Investors Millions In Perrigo Fraud Suit
Perrigo faces a legal battle over whether major investor Sculptor can exit a securities class action years after missing the opt-out deadline amid $1 billion restatements. read more
Solana Soars 18% In 1 Week: Can It Outperform Bitcoin, Ethereum?
Solana’s (CRYPTO: SOL) 18% surge over the past week comes amid strong ETF inflows and real-world adoption, fueling talk of a full-blown “SOL season” revival. read more
Chipotle Vs. Sweetgreen Vs. Cava: Who’s Winning The Bowl Battle?
Fast casual dining boom is slowing, bowl brigade (Chipotle, Sweetgreen, CAVA) struggling with stock drops, sales decline due to smaller portions and higher prices. read more
Rigetti Computing Stays The Course In Push For Quantum Advantage
Rigetti Computing, Inc. (NASDAQ: RGTI) shares are trading higher after releasing Q2 results with losses per share and revenue missing estimates. Analysts remain bullish on their technology roadmap and progress towards quantum advantage. read more